REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 189 filers reported holding REATA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.71 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $14,000 | -66.7% | 459 | +10.9% | 0.00% | 0.0% |
| Q3 2021 | $42,000 | -20.8% | 414 | +9.8% | 0.00% | -50.0% |
| Q2 2021 | $53,000 | -76.9% | 377 | -83.6% | 0.00% | -75.0% |
| Q1 2021 | $229,000 | +15.1% | 2,300 | +42.6% | 0.01% | -11.1% |
| Q4 2020 | $199,000 | +95.1% | 1,613 | +146.6% | 0.01% | -18.2% |
| Q2 2020 | $102,000 | +537.5% | 654 | +289.3% | 0.01% | +175.0% |
| Q2 2019 | $16,000 | +700.0% | 168 | +572.0% | 0.00% | +300.0% |
| Q1 2019 | $2,000 | -94.6% | 25 | -94.5% | 0.00% | -92.3% |
| Q3 2018 | $37,000 | +76.2% | 458 | -22.8% | 0.01% | +85.7% |
| Q2 2018 | $21,000 | – | 593 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
| Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
| Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
| Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
| MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
| Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
| Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
| Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |